Literature DB >> 2900016

Human erythrocyte transglutaminase: purification and preliminary characterisation.

M Signorini1, F Bortolotti, L Poltronieri, C M Bergamini.   

Abstract

Erythrocyte transglutaminase was purified by anion-exchange chromatography, size exclusion and affinity chromatography. Homogeneity was achieved by an additional step of HPLC size-exclusion chromatography. The molecular mass of the purified enzyme was calculated to be 65,000 Da by size-exclusion chromatography and sucrose-gradient centrifugation, and 92,000 Da by SDS-PAGE, thus suggesting a high degree of asymmetry. The amino-acid composition of erythrocyte transglutaminase differed substantially from that of the guinea-pig liver enzyme, notably with respect to the number of histidine, cysteine and acidic amino-acid residues. The enzyme has an absolute requirement for divalent cations for activity: calcium, manganese, and the lanthanides terbium and gadolinium activate the enzyme in decreasing order of efficacy, while no activity is displayed in the presence of magnesium. In the presence but not in the absence of calcium ions, the enzyme is rapidly inactivated by N-ethylmaleimide and by diethylpyrocarbonate suggesting that the cation influences the reactivity of amino acids essential for catalysis. When erythrocyte proteins are employed as amine acceptors in the presence of calcium, the erythrocyte transglutaminase appears to preferentially modify membrane-associated proteins, although, in the absence of calcium ions and exogenous amines, it displays a pH-dependent interaction with soluble proteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900016     DOI: 10.1515/bchm3.1988.369.1.275

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  11 in total

1.  Experimental studies investigating the pathophysiology of nephrogenic systemic fibrosis; what did we learn so far?

Authors:  Sameh K Morcos
Journal:  Eur Radiol       Date:  2010-09-17       Impact factor: 5.315

2.  Interactions of recombinant mouse erythrocyte transglutaminase with membrane skeletal proteins.

Authors:  Edgar Gutierrez; L Amy Sung
Journal:  J Membr Biol       Date:  2007-09-01       Impact factor: 1.843

Review 3.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 4.  Physiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2.

Authors:  Kajal Kanchan; Mónika Fuxreiter; László Fésüs
Journal:  Cell Mol Life Sci       Date:  2015-05-06       Impact factor: 9.261

5.  Consequences of terbium (III) binding on the conformation and enzymatic activity of guinea pig liver transglutaminase.

Authors:  K E Achyuthan; A Mary; R Bhaerman; C S Greenberg
Journal:  Mol Cell Biochem       Date:  1989-01-23       Impact factor: 3.396

6.  Studies on tissue transglutaminases: interaction of erythrocyte type-2 transglutaminase with GTP.

Authors:  C M Bergamini; M Signorini
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

7.  Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.

Authors:  Alessandra Scarpellini; Renée Germack; Hugues Lortat-Jacob; Takashi Muramatsu; Ellen Billett; Timothy Johnson; Elisabetta A M Verderio
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

Review 8.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

9.  Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.

Authors:  S Kojima; K Nara; D B Rifkin
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

10.  Transglutaminase 2 mediates UV-induced skin inflammation by enhancing inflammatory cytokine production.

Authors:  Seok-Jin Lee; Ki Baek Lee; Young Hoon Son; Jiwoong Shin; Jin-Haeng Lee; Hyo-Jun Kim; Ah-Young Hong; Hee Won Bae; Mee-Ae Kwon; Won Jong Lee; Jin-Hee Kim; Dong Hun Lee; Eui Man Jeong; In-Gyu Kim
Journal:  Cell Death Dis       Date:  2017-10-26       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.